It has been previously reported that UCP2 promotes the necrosis of damaged hepatocytes
Delaying Gastric Emptying : GLP-1 slows down the rate at which the stomach empties its contents, leading to a prolonged feeling of fullness and reduced food intake
People who achieve substantial weight loss on GLP-1 therapy often report restored menstrual regularity, improved energy for physical activity, and greater confidence in family planning
However, if you are pregnant, breastfeeding, have chronic medical conditions or take medications especially for blood sugar or metabolic disorders, consult your healthcare provider before starting
Taking injection-based therapies on consistent days and consuming balanced meals (not skipping food) stabilizes blood sugar and reduces gastric distention-related nausea
Read more: Transcarent, which recently partnered with Pharmaceutical Strategies Group to study drug trends in 2026, found that 72% of employers say high discontinuation rates and weight regain are motivating their decision not to cover GLP-1s